ResMed Net Debt from 2010 to 2024

RMD Stock

USD 233.18 0.70 0.30%

ResMed's Net Debt is increasing over the years with slightly volatile fluctuation. Overall, Net Debt is expected to go to about 667.4 M this year. Net Debt is the total debt of ResMed Inc minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1993-06-30

Previous Quarter

635.6 M

Current Value

423.9 M

Quarterly Volatility

514.1 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 227 M, Interest Expense of 48 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0138 or PTB Ratio of 4.77. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.

Check out the analysis of ResMed Correlation against competitors.

Latest ResMed's Net Debt Growth Pattern

Below is the plot of the Net Debt of ResMed Inc over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. ResMed's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

ResMed Net Debt Regression Statistics

	Arithmetic Mean	292,872,180
	Coefficient Of Variation	213.41
	Mean Deviation	514,352,168
	Median	443,566,000
	Standard Deviation	625,033,016
	Sample Variance	390666.3T
	Range	2B
	R-Value	0.79
	Mean Square Error	158816.5T
	R-Squared	0.62
	Significance	0.0005
	Slope	110,270,996
	Total Sum of Squares	5469327.8T

ResMed Net Debt History

	2024	667.4 M
	2023	635.6 M
	2022	1.4 B
	2021	643.8 M
	2020	498.4 M
	2019	836.1 M
	2018	1.1 B

Other Fundumenentals of ResMed Inc

Net Debt To E B I T D A

ResMed Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Good Will	Property Plant Equipment	Long Term Debt	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Cash And Equivalents	Net Working Capital	Capital Stock
Total Assets		0.97	0.74	0.98	0.95	0.97	0.91	0.88	-0.11	0.9	0.71	0.49	0.97	0.76	0.58	-0.65	0.98	-0.48	0.61	0.87	-0.2	-0.45	0.81	0.82	-0.68	0.06	0.7
Total Stockholder Equity	0.97		0.59	0.99	0.97	0.97	0.79	0.91	-0.14	0.78	0.65	0.46	0.92	0.74	0.39	-0.55	0.97	-0.3	0.44	0.81	-0.24	-0.46	0.71	0.82	-0.64	0.14	0.79
Net Debt	0.74	0.59		0.64	0.6	0.63	0.9	0.4	-0.19	0.94	0.82	0.15	0.85	0.43	0.86	-0.49	0.73	-0.76	0.78	0.7	-0.05	-0.42	0.86	0.64	-0.69	-0.15	0.32
Retained Earnings	0.98	0.99	0.64		0.98	0.98	0.83	0.9	-0.09	0.82	0.64	0.49	0.94	0.74	0.45	-0.63	0.97	-0.39	0.51	0.85	-0.16	-0.44	0.75	0.79	-0.67	0.08	0.76
Accounts Payable	0.95	0.97	0.6	0.98		0.96	0.79	0.85	-0.13	0.8	0.64	0.44	0.92	0.69	0.39	-0.58	0.95	-0.41	0.53	0.83	-0.22	-0.46	0.74	0.75	-0.65	0.03	0.82
Net Receivables	0.97	0.97	0.63	0.98	0.96		0.84	0.88	-0.11	0.84	0.61	0.55	0.93	0.74	0.46	-0.69	0.95	-0.46	0.54	0.87	-0.14	-0.43	0.76	0.72	-0.72	-0.04	0.72
Total Liab	0.91	0.79	0.9	0.83	0.79	0.84		0.71	-0.06	0.98	0.73	0.49	0.93	0.68	0.83	-0.73	0.87	-0.74	0.82	0.85	-0.12	-0.38	0.88	0.7	-0.65	-0.09	0.43
Total Current Assets	0.88	0.91	0.4	0.9	0.85	0.88	0.71		0.11	0.63	0.41	0.65	0.75	0.8	0.38	-0.65	0.82	-0.18	0.42	0.72	-0.26	-0.21	0.52	0.73	-0.37	0.33	0.62
Short Term Debt	-0.11	-0.14	-0.19	-0.09	-0.13	-0.11	-0.06	0.11		-0.16	-0.44	0.18	-0.2	-0.07	-0.03	-0.14	-0.22	0.02	0.11	-0.06	0.19	0.49	-0.29	-0.17	0.45	0.31	-0.12
Intangible Assets	0.9	0.78	0.94	0.82	0.8	0.84	0.98	0.63	-0.16		0.79	0.38	0.95	0.6	0.79	-0.64	0.89	-0.78	0.81	0.83	-0.12	-0.46	0.91	0.69	-0.74	-0.18	0.5
Short Term Investments	0.71	0.65	0.82	0.64	0.64	0.61	0.73	0.41	-0.44	0.79		0.06	0.81	0.54	0.58	-0.23	0.79	-0.42	0.51	0.68	-0.46	-0.61	0.85	0.82	-0.66	-0.02	0.51
Common Stock	0.49	0.46	0.15	0.49	0.44	0.55	0.49	0.65	0.18	0.38	0.06		0.35	0.81	0.36	-0.84	0.41	-0.32	0.42	0.64	-0.02	-0.12	0.43	0.25	-0.27	-0.07	0.17
Good Will	0.97	0.92	0.85	0.94	0.92	0.93	0.93	0.75	-0.2	0.95	0.81	0.35		0.66	0.63	-0.57	0.98	-0.58	0.66	0.86	-0.17	-0.51	0.89	0.8	-0.76	-0.05	0.68
Property Plant Equipment	0.76	0.74	0.43	0.74	0.69	0.74	0.68	0.8	-0.07	0.6	0.54	0.81	0.66		0.45	-0.69	0.73	-0.23	0.43	0.84	-0.27	-0.38	0.71	0.7	-0.44	0.14	0.47
Long Term Debt	0.58	0.39	0.86	0.45	0.39	0.46	0.83	0.38	-0.03	0.79	0.58	0.36	0.63	0.45		-0.6	0.5	-0.76	0.88	0.59	0.01	-0.06	0.7	0.49	-0.38	-0.03	0.05
Treasury Stock	-0.65	-0.55	-0.49	-0.63	-0.58	-0.69	-0.73	-0.65	-0.14	-0.64	-0.23	-0.84	-0.57	-0.69	-0.6		-0.56	0.6	-0.64	-0.78	-0.13	0.2	-0.61	-0.26	0.48	0.28	-0.12
Current Deferred Revenue	0.98	0.97	0.73	0.97	0.95	0.95	0.87	0.82	-0.22	0.89	0.79	0.41	0.98	0.73	0.5	-0.56		-0.45	0.55	0.85	-0.29	-0.56	0.83	0.83	-0.73	0.0	0.73
Net Tangible Assets	-0.48	-0.3	-0.76	-0.39	-0.41	-0.46	-0.74	-0.18	0.02	-0.78	-0.42	-0.32	-0.58	-0.23	-0.76	0.6	-0.45		-0.87	-0.53	-0.15	0.23	-0.67	-0.16	0.52	0.53	-0.11
Long Term Debt Total	0.61	0.44	0.78	0.51	0.53	0.54	0.82	0.42	0.11	0.81	0.51	0.42	0.66	0.43	0.88	-0.64	0.55	-0.87		0.65	-0.02	-0.03	0.72	0.39	-0.38	-0.17	0.23
Capital Surpluse	0.87	0.81	0.7	0.85	0.83	0.87	0.85	0.72	-0.06	0.83	0.68	0.64	0.86	0.84	0.59	-0.78	0.85	-0.53	0.65		-0.1	-0.44	0.91	0.68	-0.71	-0.12	0.55
Deferred Long Term Liab	-0.2	-0.24	-0.05	-0.16	-0.22	-0.14	-0.12	-0.26	0.19	-0.12	-0.46	-0.02	-0.17	-0.27	0.01	-0.13	-0.29	-0.15	-0.02	-0.1		0.41	-0.1	-0.44	0.0	-0.25	-0.21
Short Long Term Debt	-0.45	-0.46	-0.42	-0.44	-0.46	-0.43	-0.38	-0.21	0.49	-0.46	-0.61	-0.12	-0.51	-0.38	-0.06	0.2	-0.56	0.23	-0.03	-0.44	0.41		-0.51	-0.41	0.67	0.31	-0.33
Long Term Investments	0.81	0.71	0.86	0.75	0.74	0.76	0.88	0.52	-0.29	0.91	0.85	0.43	0.89	0.71	0.7	-0.61	0.83	-0.67	0.72	0.91	-0.1	-0.51		0.67	-0.79	-0.26	0.49
Net Invested Capital	0.82	0.82	0.64	0.79	0.75	0.72	0.7	0.73	-0.17	0.69	0.82	0.25	0.8	0.7	0.49	-0.26	0.83	-0.16	0.39	0.68	-0.44	-0.41	0.67		-0.46	0.46	0.72
Cash And Equivalents	-0.68	-0.64	-0.69	-0.67	-0.65	-0.72	-0.65	-0.37	0.45	-0.74	-0.66	-0.27	-0.76	-0.44	-0.38	0.48	-0.73	0.52	-0.38	-0.71	0.0	0.67	-0.79	-0.46		0.47	-0.43
Net Working Capital	0.06	0.14	-0.15	0.08	0.03	-0.04	-0.09	0.33	0.31	-0.18	-0.02	-0.07	-0.05	0.14	-0.03	0.28	0.0	0.53	-0.17	-0.12	-0.25	0.31	-0.26	0.46	0.47		0.25
Capital Stock	0.7	0.79	0.32	0.76	0.82	0.72	0.43	0.62	-0.12	0.5	0.51	0.17	0.68	0.47	0.05	-0.12	0.73	-0.11	0.23	0.55	-0.21	-0.33	0.49	0.72	-0.43	0.25

Click cells to compare fundamentals

About ResMed Financial Statements

ResMed stakeholders use historical fundamental indicators, such as ResMed's Net Debt, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	635.6 M	667.4 M
Net Debt To EBITDA	0.41	0.44

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:

How To Invest In ResMed

Details

Is ResMed Stock a good investment?

Details

What is ResMed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of ResMed Correlation against competitors.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.416

Dividend Share

1.97

Earnings Share

7.53

Revenue Per Share

32.711

Quarterly Revenue Growth

0.111

The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ResMed Net Debt from 2010 to 2024

Latest ResMed's Net Debt Growth Pattern

ResMed Net Debt Regression Statistics

ResMed Net Debt History

Other Fundumenentals of ResMed Inc

ResMed Net Debt component correlations

About ResMed Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY